Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Who this might be right for
Glioblastoma
University College, London 38